![Pamela Stephenson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pamela Stephenson
Corporate Officer/Principal bei
DISC MEDICINE, INC.
Vermögen: 1 Mio $ am 31.05.2026
Profil
Pamela Stephenson is Chief Commercial Officer at Disc Medicine, Inc. since 2024.
Formerly, Ms. Stephenson was Chief Commercial Officer at Albireo Pharma, Inc. from 2019 to 2023, Independent Director at Harmony Biosciences Management, Inc. from 2019 to 2023, and Vice President-Global Market Access & Value at Vertex Pharmaceuticals, Inc. from 2008 to 2019.
Education includes undergraduate studies at Brown University and graduate studies at Boston University School of Public Health.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DISC MEDICINE, INC. 0.05% | 22.04.2026 | 18’665 ( 0.05% ) | 1 Mio $ | 31.05.2026 |
Aktive Positionen von Pamela Stephenson
| Unternehmen | Position | Beginn |
|---|---|---|
| DISC MEDICINE, INC. | Corporate Officer/Principal | 26.02.2024 |
Ehemalige bekannte Positionen von Pamela Stephenson
| Unternehmen | Position | Ende |
|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 10.10.2023 |
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 01.04.2023 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01.03.2019 |
Ausbildung von Pamela Stephenson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
61
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Zynerba Pharmaceuticals, Inc.
 Zynerba Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Delivers dermal solutions for the treatment of neuroscience disorders | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Public Health
 Boston University School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Disc Medicine, Inc.
 Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
Wählen Sie MarketScreener 
